Retrospective review of snake bite victims.

Muhammad H. Nazim, Sanjay Gupta, Syed Hashmi, Jamshed Zuberi, Alison Wilson, Lawrence Roberts, Kamran Karimi

Research output: Contribution to journalArticle

Abstract

Venomous snakebites are a rare but dangerous and potentially deadly condition in the U.S.. Most bites in the U. S. result from envenomation with snakes of the family Viperidae, subfamily Crotalinae, which includes rattlesnakes and copperheads. Treatment includes a comprehensive work-up to look for possible hematologic, neurologic, renal, and cardiovascular abnormalities, local wound care, systemic antivenom administration, tetanus prophylaxis, antibiotics in the presence of infection and surgical treatment if needed, which may include debridement, fasciotomy and rarely amputation. All these patients should be observed for a minimum of 8 hours. Any evidence of envenomation mandates a minimum of 24 hours of in-hospital observation. A grading system to classify the severity of envenomation is described. The most commonly used antivenom in the U.S. is CroFab, which has a much lower incidence of acute or delayed allergic reactions compared to the older antivenoms. When allergic reactions do occur, they are usually of mild to moderate severity. With the improved risk-benefit ratio of CroFab, antivenom is indicated with any grade of envenomation. In this a retrospective study, we will review our experience with 25 snakebite victims admitted to the West Virginia University over a five years period.

Original languageEnglish (US)
Pages (from-to)30-34
Number of pages5
JournalThe West Virginia medical journal
Volume104
Issue number5
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Antivenins
Snake Bites
Hypersensitivity
Agkistrodon
Cardiovascular Abnormalities
Crotalus
Nervous System Malformations
Antibiotic Prophylaxis
Tetanus
Debridement
Bites and Stings
Viperidae
Amputation
Retrospective Studies
Odds Ratio
Observation
Kidney
Incidence
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nazim, M. H., Gupta, S., Hashmi, S., Zuberi, J., Wilson, A., Roberts, L., & Karimi, K. (2008). Retrospective review of snake bite victims. The West Virginia medical journal, 104(5), 30-34.

Retrospective review of snake bite victims. / Nazim, Muhammad H.; Gupta, Sanjay; Hashmi, Syed; Zuberi, Jamshed; Wilson, Alison; Roberts, Lawrence; Karimi, Kamran.

In: The West Virginia medical journal, Vol. 104, No. 5, 09.2008, p. 30-34.

Research output: Contribution to journalArticle

Nazim, MH, Gupta, S, Hashmi, S, Zuberi, J, Wilson, A, Roberts, L & Karimi, K 2008, 'Retrospective review of snake bite victims.', The West Virginia medical journal, vol. 104, no. 5, pp. 30-34.
Nazim MH, Gupta S, Hashmi S, Zuberi J, Wilson A, Roberts L et al. Retrospective review of snake bite victims. The West Virginia medical journal. 2008 Sep;104(5):30-34.
Nazim, Muhammad H. ; Gupta, Sanjay ; Hashmi, Syed ; Zuberi, Jamshed ; Wilson, Alison ; Roberts, Lawrence ; Karimi, Kamran. / Retrospective review of snake bite victims. In: The West Virginia medical journal. 2008 ; Vol. 104, No. 5. pp. 30-34.
@article{ecc05432436d452c9b08fe8093ed0907,
title = "Retrospective review of snake bite victims.",
abstract = "Venomous snakebites are a rare but dangerous and potentially deadly condition in the U.S.. Most bites in the U. S. result from envenomation with snakes of the family Viperidae, subfamily Crotalinae, which includes rattlesnakes and copperheads. Treatment includes a comprehensive work-up to look for possible hematologic, neurologic, renal, and cardiovascular abnormalities, local wound care, systemic antivenom administration, tetanus prophylaxis, antibiotics in the presence of infection and surgical treatment if needed, which may include debridement, fasciotomy and rarely amputation. All these patients should be observed for a minimum of 8 hours. Any evidence of envenomation mandates a minimum of 24 hours of in-hospital observation. A grading system to classify the severity of envenomation is described. The most commonly used antivenom in the U.S. is CroFab, which has a much lower incidence of acute or delayed allergic reactions compared to the older antivenoms. When allergic reactions do occur, they are usually of mild to moderate severity. With the improved risk-benefit ratio of CroFab, antivenom is indicated with any grade of envenomation. In this a retrospective study, we will review our experience with 25 snakebite victims admitted to the West Virginia University over a five years period.",
author = "Nazim, {Muhammad H.} and Sanjay Gupta and Syed Hashmi and Jamshed Zuberi and Alison Wilson and Lawrence Roberts and Kamran Karimi",
year = "2008",
month = "9",
language = "English (US)",
volume = "104",
pages = "30--34",
journal = "West Virginia Medical Journal",
issn = "0043-3284",
publisher = "West Virginia State Medical Association",
number = "5",

}

TY - JOUR

T1 - Retrospective review of snake bite victims.

AU - Nazim, Muhammad H.

AU - Gupta, Sanjay

AU - Hashmi, Syed

AU - Zuberi, Jamshed

AU - Wilson, Alison

AU - Roberts, Lawrence

AU - Karimi, Kamran

PY - 2008/9

Y1 - 2008/9

N2 - Venomous snakebites are a rare but dangerous and potentially deadly condition in the U.S.. Most bites in the U. S. result from envenomation with snakes of the family Viperidae, subfamily Crotalinae, which includes rattlesnakes and copperheads. Treatment includes a comprehensive work-up to look for possible hematologic, neurologic, renal, and cardiovascular abnormalities, local wound care, systemic antivenom administration, tetanus prophylaxis, antibiotics in the presence of infection and surgical treatment if needed, which may include debridement, fasciotomy and rarely amputation. All these patients should be observed for a minimum of 8 hours. Any evidence of envenomation mandates a minimum of 24 hours of in-hospital observation. A grading system to classify the severity of envenomation is described. The most commonly used antivenom in the U.S. is CroFab, which has a much lower incidence of acute or delayed allergic reactions compared to the older antivenoms. When allergic reactions do occur, they are usually of mild to moderate severity. With the improved risk-benefit ratio of CroFab, antivenom is indicated with any grade of envenomation. In this a retrospective study, we will review our experience with 25 snakebite victims admitted to the West Virginia University over a five years period.

AB - Venomous snakebites are a rare but dangerous and potentially deadly condition in the U.S.. Most bites in the U. S. result from envenomation with snakes of the family Viperidae, subfamily Crotalinae, which includes rattlesnakes and copperheads. Treatment includes a comprehensive work-up to look for possible hematologic, neurologic, renal, and cardiovascular abnormalities, local wound care, systemic antivenom administration, tetanus prophylaxis, antibiotics in the presence of infection and surgical treatment if needed, which may include debridement, fasciotomy and rarely amputation. All these patients should be observed for a minimum of 8 hours. Any evidence of envenomation mandates a minimum of 24 hours of in-hospital observation. A grading system to classify the severity of envenomation is described. The most commonly used antivenom in the U.S. is CroFab, which has a much lower incidence of acute or delayed allergic reactions compared to the older antivenoms. When allergic reactions do occur, they are usually of mild to moderate severity. With the improved risk-benefit ratio of CroFab, antivenom is indicated with any grade of envenomation. In this a retrospective study, we will review our experience with 25 snakebite victims admitted to the West Virginia University over a five years period.

UR - http://www.scopus.com/inward/record.url?scp=58149149506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149149506&partnerID=8YFLogxK

M3 - Article

C2 - 18846756

AN - SCOPUS:58149149506

VL - 104

SP - 30

EP - 34

JO - West Virginia Medical Journal

JF - West Virginia Medical Journal

SN - 0043-3284

IS - 5

ER -